Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jasper Littmann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Vaccine|December 3, 2014
How high is a high risk? Prioritising high-risk individuals in an influenza pandemicJasper Littmann
Journal of Public Health (Oxford, England)|February 26, 2013
Comment on Marchman Andersen et al.: social inequality in health, responsibility and egalitarian justiceJasper Littmann
Trials|July 4, 2012
Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical dataDaniel Strech, Jasper Littmann
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 15, 2018
[Rational use of antibiotics as an ethical challenge]Jasper Littmann, Alena Buyx
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 6, 2019
Antimicrobial resistance is a super wicked problemJasper Littmann, Gunnar Skov Simonsen
Public Health Ethics|November 14, 2015
Is Antimicrobial Resistance a Slowly Emerging Disaster?A M Viens, Jasper Littmann
Public Health Ethics|November 14, 2015
The Ethical Significance of Antimicrobial ResistanceJasper Littmann, A M Viens
European Journal of Public Health|October 17, 2017
Tackling anti-microbial resistance: ethical framework for rational antibiotic useJasper Littmann, Annette Rid, Alena Buyx
Bioethics|August 20, 2019
Evaluating the risks of public health programs: Rational antibiotic use and antimicrobial resistanceAnnette Rid, Jasper Littmann, Alena Buyx
International Journal of Antimicrobial Agents|August 6, 2015
Antibiotic resistance: An ethical challengeJasper Littmann, Alena Buyx, Otto Cars
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Vaccine|December 3, 2014
How high is a high risk? Prioritising high-risk individuals in an influenza pandemicJasper Littmann
Journal of Public Health (Oxford, England)|February 26, 2013
Comment on Marchman Andersen et al.: social inequality in health, responsibility and egalitarian justiceJasper Littmann
Trials|July 4, 2012
Lack of proportionality. Seven specifications of public interest that override post-approval commercial interests on limited access to clinical dataDaniel Strech, Jasper Littmann
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 15, 2018
[Rational use of antibiotics as an ethical challenge]Jasper Littmann, Alena Buyx
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 6, 2019
Antimicrobial resistance is a super wicked problemJasper Littmann, Gunnar Skov Simonsen
Public Health Ethics|November 14, 2015
Is Antimicrobial Resistance a Slowly Emerging Disaster?A M Viens, Jasper Littmann
Public Health Ethics|November 14, 2015
The Ethical Significance of Antimicrobial ResistanceJasper Littmann, A M Viens
European Journal of Public Health|October 17, 2017
Tackling anti-microbial resistance: ethical framework for rational antibiotic useJasper Littmann, Annette Rid, Alena Buyx
Bioethics|August 20, 2019
Evaluating the risks of public health programs: Rational antibiotic use and antimicrobial resistanceAnnette Rid, Jasper Littmann, Alena Buyx
International Journal of Antimicrobial Agents|August 6, 2015
Antibiotic resistance: An ethical challengeJasper Littmann, Alena Buyx, Otto Cars
Pageof 2